Richard A. Fair
Net Worth

Last updated:

What is Richard A. Fair net worth?

The estimated net worth of Mr. Richard A. Fair is at least $5,379,180 as of 17 Mar 2020. He has received compensation worth at least $5,379,180 in Bellicum Pharmaceuticals, Inc..

What is the salary of Richard A. Fair?

Mr. Richard A. Fair salary is $896,530 per year as Pres, Chief Executive Officer & Director in Bellicum Pharmaceuticals, Inc..

How old is Richard A. Fair?

Mr. Richard A. Fair is 56 years old, born in 1969.

What stocks does Richard A. Fair currently own?

As insider, Mr. Richard A. Fair owns shares in one company:

Company Title Shares Price per share Total value
Bellicum Pharmaceuticals, Inc. (BLCM) Pres, Chief Executive Officer & Director 5,000 $0 $0

What does Bellicum Pharmaceuticals, Inc. do?

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes in the treatment of leukemias, lymphomas, and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas.

Richard A. Fair insider trading

Bellicum Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $4 $20,000
Purchase
Common Stock 40,000 $1.25 $50,000
Purchase
Common Stock 20,000 $0.99 $19,780

Bellicum Pharmaceuticals key executives

Bellicum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: